71372 Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 

Bethesda, MD 20892, (301) 594–2138, 

partlowkc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Drug Discovery Involving the 

Nervous System. 

Date: November 16–17, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lai Yee Leung, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1011D, 

Bethesda, MD 20892, (301) 827–8106, 

leungl2@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 11, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–22769 Filed 10–13–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Request for Information; Potential 

Changes to its Evidence-Based 

Practices Resource Center; Notice of 

Correction 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice; correction. 

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

published a document in the Federal 

Register of September 7, 2023, 

announcing a Notice of request for 

information (RFI). The document 

contained incorrect date in the DATES

section. 

FOR FURTHER INFORMATION CONTACT: 

Carter A Roeber, Telephone number 

(240) 276–1488, Email: Carter.Roeber@

samhsa.hhs.gov, or EBPRC@

samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of September 

7, 2023, in FR Doc. 2023–19272, on 

pages 61608 and 61609, in the second 

column, correct the DATES caption to 

read: 

Comments or feedback on this notice 

must be received by end of business 

day, November 7, 2023. 

Dated: October 11, 2023. 

Carlos Castillo, 

Committee Management Officer. 

[FR Doc. 2023–22792 Filed 10–13–23; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

Extension and Expansion of 

Declaration Zone Test 

AGENCY: U.S. Customs and Border 

Protection, DHS. 

ACTION: General notice. 

SUMMARY: On August 30, 2021, U.S. 

Customs and Border Protection (CBP) 

announced in the Federal Register that 

CBP would conduct a Declaration Zone 

test at cruise terminal facilities at 

participating sea ports of entry (POEs) 

that would run for approximately two 

years. This document announces that 

CBP is extending the test period for an 

additional two years. In addition to the 

extension, this document announces 

that CBP intends to expand the 

Declaration Zone test to up to eighteen 

additional sea POEs, as well as to 

travelers being processed in Simplified 

Arrival for open loop cruises. The 

Declaration Zone test allows for 

streamlined processing by allowing a 

demonstrative initial declaration for 

arriving travelers in lieu of an oral or 

written declaration of all articles 

brought into the United States to a CBP 

officer as required by current CBP 

regulations. 

DATES: CBP is extending the Declaration 

Zone test at cruise terminal facilities at 

participating sea POEs until October 16, 

2025. CBP is expanding the Declaration 

Zone test to eligible open loop cruises 

no sooner than October 1, 2023. The 

expansion date may vary at each 

location. 

ADDRESSES: Written comments 

concerning program, policy, and 

technical issues may be submitted at 

any time during the test period via 

email to BiometricSea@cbp.dhs.gov. 

Please use ‘‘Comment on Declaration 

Zone Test’’ in the subject line of the 

email. 

FOR FURTHER INFORMATION CONTACT: 

Maria Rivera, Program Manager, 

Biometric Entry-Exit Strategic 

Transformation, Office of Field 

Operations, maria.c.rivera@cbp.dhs.gov 

or (202) 325–4596. 

SUPPLEMENTARY INFORMATION: 

Background 

On August 30, 2021, U.S. Customs 

and Border Protection (CBP) announced 

in the Federal Register (86 FR 48436) 

that CBP would conduct a Declaration 

Zone test at cruise terminal facilities at 

participating sea ports of entry (POEs). 

The notice describes the Declaration 

Zone test, while setting forth 

requirements for participating in the 

test, the duration of the test, and how 

CBP will evaluate the test. The notice 

also invites public comment on any 

aspect of the test. In brief, the 

Declaration Zone test fulfills the 

declaration requirement under CBP 

regulations, while also allowing for 

streamlined processing. Current CBP 

regulations require each traveler to 

provide an oral or written declaration of 

all articles brought into the United 

States to a CBP officer. See 19 CFR part 

148, subpart B. The Declaration Zone 

test provides arriving travelers with an 

alternative method to meet this 

requirement by allowing a 

demonstrative initial declaration 

through the use of declaration zones at 

cruise terminal facilities at select sea 

POEs. 

Description and Procedures 

The 2021 notice provides the 

description and procedures for the 

Declaration Zone test. 86 FR 48437. 

Within a cruise terminal facility 

participating in the Declaration Zone 

test, two distinct customs declaration 

zone queues are established for entering 

the egress area: one for No Items to 

Declare and another for Items to 

Declare. Signage is posted to clearly 

label the queues at the entrance to the 

egress area after travelers collect their 

luggage. The physical act of selecting 

the No Items to Declare queue or the 

Items to Declare queue in and of itself 

constitutes an initial demonstrative 

declaration. CBP officers conduct roving 

enforcement operations within the 

baggage collection and egress area to 

ensure traveler compliance. 

No Items To Declare Queue 

Travelers who determine they have 

nothing to declare enter the No Items to 

Declare queue and proceed through the 

egress area to the facility exit. CBP 

officers conduct roving operations in the 

No Items to Declare zone to affirm 

traveler compliance, receive oral 

declarations, and make referrals to 

secondary inspection as necessary. 

Travelers who are not questioned by 

CBP officers conducting roving 

operations may proceed to the exit. 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 198 / Monday, October 16, 2023 / Notices 71373 

1Simplified Arrival is an enhanced international 

arrival process that uses facial biometrics to 

automate the manual document checks that are 

already required for admission into the United 

States. More information on CBP’s use of facial 

biometrics to secure and streamline travel can be 

found at https://www.cbp.gov/travel/biometrics. 

2 86 FR 48437. 3 86 FR 48437. 

Items To Declare Queue 

Travelers with items to declare enter 

the Items to Declare queue and present 

before a CBP officer to make an oral 

declaration. The CBP officer makes a 

determination if duty is owed by the 

traveler or if additional inspection is 

warranted. The CBP officer then directs 

the traveler accordingly. 

Referral to Secondary Inspection 

If a traveler is referred to secondary 

inspection at any point, CBP officers 

will follow standard procedures, 

including collecting an oral and/or 

written declaration during the referral 

and inspection. CBP officers will also 

follow current agency policy on 

declaration amendment opportunities. 

Test Period and Participants 

As indicated in the 2021 notice, the 

Declaration Zone test was set to begin 

no earlier than September 27, 2021, and 

run for approximately two years, 

initially at two sea POEs, Miami, 

Florida, and Bayonne, New Jersey. 86 

FR 48436–7. The 2021 notice stated that 

the start date may vary at each location 

in accordance with the resumption of 

passenger operations suspended due to 

the COVID–19 pandemic. 86 FR 48437. 

Also, as indicated in the 2021 notice, 

the test is currently restricted to closed 

loop cruises participating in the 

voluntary facial biometric debarkation 

(FBD) program. 86 FR 48437. 

Extension of the Declaration Zone Test 

Period and Expansion of the 

Declaration Zone Test 

Extension of the Test Period 

Based on limited cruise line 

operations and the suspension of 

passenger operations due to the COVID– 

19 pandemic, CBP was not able to 

implement the Declaration Zone test 

until May 2022 in Bayonne and July 

2022 in Miami. Due to this 

postponement, CBP is extending the 

Declaration Zone test for an additional 

two years until October 16, 2025, to 

properly assess and evaluate the impact 

of the new form of declaration. 

Expansion of the Test 

Additional Sea POEs 

In addition to the extension of the test 

period, to better evaluate the 

Declaration Zone test, CBP also intends 

to expand the Declaration Zone test to 

cruise terminal facilities at up to 

eighteen additional sea POE locations. 

CBP will only expand the Declaration 

Zone test to cruise terminal facilities at 

sea POEs with the sufficient space and 

infrastructure to accommodate queuing 

for processing through a Declaration 

Zone. CBP Headquarters will 

communicate with each Field Office 

and POE with cruise terminal facilities 

meeting these criteria and advise of the 

option to have a Declaration Zone test 

at their respective terminal(s). As 

provided in the 2021 notice, once a new 

location is identified, CBP will 

announce the expansion on the public 

facing CBP website, https://

www.cbp.gov, notifying the traveling 

public of the implementation of 

demonstrative declarations upon arrival 

into the United States at that particular 

sea POE. 86 FR 48437. 

Eligible Open Loop Cruises 

Additionally, CBP is expanding the 

Declaration Zone test to travelers being 

processed in Simplified Arrival for open 

loop cruises. When the Declaration 

Zone test was initially announced in 

2021, it was limited to passengers on 

closed loop cruises processed in FBD. 

FBD is the facial biometric solution for 

processing arriving cruise passengers on 

closed loop cruises, whereas Simplified 

Arrival is an equivalent facial biometric 

solution for processing arriving cruise 

passengers on open loop cruises.1 The 

test will no longer be restricted to closed 

loop cruises and will expand to open 

loop cruises participating in Simplified 

Arrival no sooner than October 1, 2023. 

The expansion date may vary at each 

location. 

Authorization for the Test 

The test described in the 2021 notice 2

and extended and expanded by this 

notice is authorized pursuant to 19 CFR 

101.9(a), which allows the 

Commissioner of CBP to impose 

requirements different from those 

specified in the CBP Regulations for 

purposes of conducting a test program 

or procedure designed to evaluate the 

effectiveness of new operational 

procedures regarding the processing of 

passengers. This test is authorized 

pursuant to this regulation as it is 

designed to evaluate whether allowing a 

demonstrative initial declaration is a 

feasible way to fulfill the declaration 

requirement and allow for streamlined 

processing. 

Waiver of Certain Regulatory 

Requirements 

CBP regulations require each traveler 

to provide an oral or written declaration 

of all articles brought into the United 

States to a CBP officer. See 19 CFR 

148.12 and 148.13. The test described in 

the 2021 notice 3 and extended and 

expanded by this notice provides 

arriving travelers with an alternative 

method to meet this requirement by 

allowing a demonstrative initial 

declaration. All other requirements of 

19 CFR part 148, subpart B, regarding 

declarations, including those provided 

by 19 CFR 148.18, regarding failure to 

declare, and 19 CFR 148.19, regarding 

false or fraudulent statements, still 

apply. 

Dated: October 10, 2023. 

Diane J. Sabatino, 

Acting Executive Assistant Commissioner, 

Office of Field Operations, U.S. Customs and 

Border Protection. 

[FR Doc. 2023–22714 Filed 10–13–23; 8:45 am] 

BILLING CODE 9111–14–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

[OMB Control Number 1615–0099] 

Agency Information Collection 

Activities; Extension, Without Change, 

of a Currently Approved Collection: 

Application for T Nonimmigrant Status 

AGENCY: U.S. Citizenship and 

Immigration Services, Department of 

Homeland Security. 

ACTION: 30-Day notice. 

SUMMARY: The Department of Homeland 

Security (DHS), U.S. Citizenship and 

Immigration Services (USCIS) will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The purpose of this notice is to 

allow an additional 30 days for public 

comments. 

DATES: Comments are encouraged and 

will be accepted until November 15, 

2023. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice, especially 

regarding the estimated public burden 

and associated response time, must be 

submitted via the Federal eRulemaking 

Portal website at https://

www.regulations.gov under e-Docket ID 

number USCIS–2006–0059. 

FOR FURTHER INFORMATION CONTACT: 

USCIS, Office of Policy and Strategy, 


ddrumheller on DSK120RN23PROD with NOTICES1